G6PD deficiency among malaria-infected national groups at the western part of Myanmar with implications for primaquine use in malaria elimination

BACKGROUND: Glucose 6-phosphate dehydrogenase deficiency (G6PDd) plays a central role in readiness assessment for malaria elimination in Myanmar by 2030 that includes primaquine (PQ) use. The risk of hemolysis in G6PDd individuals hampers the widespread use of primaquine safely in malaria-infected p...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Kay Thwe, Han, Zay Yar, Aye, Kyin Hla, Wai, Khin Thet, Thi, Aung, Cui, Liwang, Sattabongkot, Jetsumon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191138/
https://www.ncbi.nlm.nih.gov/pubmed/34108049
http://dx.doi.org/10.1186/s41182-021-00339-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191138/
https://www.ncbi.nlm.nih.gov/pubmed/34108049
http://dx.doi.org/10.1186/s41182-021-00339-7

Ejemplares similares